Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Scott Mann Insider Profile

4 Followers

Michael Scott Mann, President at Endonovo Therapeutics, holds 26.79M shares in Endonovo Therapeutics (Ticker: ENDV). Most recently, Michael Scott Mann Bought 5,000 shares of Endonovo Therapeutics on Apr 09, 2019 for an estimated value of $50.00.

Michael Scott Mann's Trading History

ENDV
Endonovo Therapeutics
Apr 09, 2019PresidentInformative Buy50.00―
ENDV
Insider Shares: 26.79M (3.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 09, 2019Informative Buy$50.005,000$0.01-99.20%
Mar 26, 2019Informative Buy$240.0022,000$0.01-98.90%
Mar 22, 2019Informative Buy$40.002,000$0.02-99.00%
Mar 13, 2019Informative Buy$860.0056,000$0.01-98.80%
Feb 08, 2019Informative Buy$80.004,000$0.02-94.20%

You May Also Like

Michael Scott Mann insider profile FAQ

What is the percentage of profitable transactions made by Michael Scott Mann?
The percentage of profitable transactions made by Michael Scott Mann is 0%.
What is the average return per transaction made by Michael Scott Mann?
The average return per transaction made by Michael Scott Mann is -96.20%.
What stocks does Michael Scott Mann hold?
Michael Scott Mann holds: ENDV stocks.
What was Michael Scott Mann’s latest transaction?
Michael Scott Mann’s latest transaction was an Informative Buy of $50.00.
What was Michael Scott Mann's most profitable transaction?
Michael Scott Mann’s most profitable transaction was an Informative Buy of ENDV stock on January 3, 2019. The return on the trade was -91.90%.
What is Michael Scott Mann's role in Endonovo Therapeutics?
Michael Scott Mann's role in Endonovo Therapeutics is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.